Literature DB >> 2795213

Caffeine reduces dipyridamole-induced myocardial ischemia.

P Smits1, W R Aengevaeren, F H Corstens, T Thien.   

Abstract

The mechanism of action of coronary vasodilation after dipyridamole may be based on inhibition of cellular uptake of circulating endogenous adenosine. Since caffeine has been reported to be a competitive antagonist of adenosine we studied the effect of caffeine on the outcome of dipiridamole-201Tl cardiac imaging in one patient. During caffeine abstinence dipyridamole induced myocardial ischemia with down-slope ST depressions on the ECG, and reversible perfusion defects on the scintigrams. When the test was repeated 1 wk later on similar conditions, but now shortly after infusion of caffeine (4 mg/kg), the ECG showed no, and the scintigrams only slight signs of ischemia. We conclude that when caffeine abstinence is not sufficient, the widespread use of coffee and related products may be responsible for false-negative findings in dipyridamole-201Tl cardiac imaging.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2795213

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

Review 1.  The impact of caffeine on vasodilator stress perfusion studies.

Authors:  Andre C Lapeyre; Tauqir Y Goraya; Donald L Johnston; Raymond J Gibbons
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

2.  Effect of caffeine on adenosine-induced reversible perfusion defects assessed by automated analysis.

Authors:  Joseph C Lee; John F Fraser; Adrian G Barnett; Leslie P Johnson; Melinda G Wilson; Catherine M McHenry; Darren L Walters; Christopher R Warnholtz; Frederick A Khafagi
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

3.  The effect of caffeine on adenosine myocardial perfusion imaging: time to reassess?

Authors:  Fadi G Hage; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

4.  Caffeine does not significantly reduce the sensitivity of vasodilator stress myocardial perfusion imaging.

Authors:  Rayan Saab; Navkaranbir S Bajaj; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-12-14       Impact factor: 5.952

5.  The judgement of the eye.

Authors:  Timothy F Christian
Journal:  J Nucl Cardiol       Date:  2016-02-16       Impact factor: 5.952

6.  Symptom-limited exercise during vasodilator stress: best of both worlds?

Authors:  Kevin A Bybee; Timothy M Bateman
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

Review 7.  Practicing safe SPECT: caffeine abstinence in nuclear myocardial perfusion imaging.

Authors:  Kristina E Powles; Renee C Hessian; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

Review 8.  Pharmacology of coronary vasodilation: a brief review.

Authors:  C Orlandi
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

9.  ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers.

Authors:  Milena J Henzlova; W Lane Duvall; Andrew J Einstein; Mark I Travin; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2016-06       Impact factor: 5.952

10.  Serum caffeine levels after 24 hours of caffeine abstention: observations on clinical patients undergoing myocardial perfusion imaging with dipyridamole or adenosine.

Authors:  A F Jacobson; M D Cerqueira; V Raisys; S Shattuc
Journal:  Eur J Nucl Med       Date:  1994-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.